13.80
-0.01(-0.07%)
Currency In CNY
Address
Renxin industrial park
Heze, 274100
China
Phone
86 53 0226 3536
Website
Sector
Healthcare
Industry
Biotechnology
Employees
959
First IPO Date
January 09, 2017
| Name | Title | Pay | Year Born |
| Fuwen Li | Chief Financial Officer | 0 | 1976 |
| Lianbiao Jin | General Manager | 0 | 1965 |
| Lu Li | Deputy GM, Board Secretary & Director | 0 | 1977 |
| Yong Hong Wang | Accounting Supervisor | 0 | N/A |
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal, acid removal, 3-ketal, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.